🚨 New preprint!🚨 Tackling non-small cell lung cancer (NSCLC) adenocarcinoma with in silico models:

🌟 Models tumor pathways (EGFR, AKT, JAK/STAT, WNT)
🌟 personalized drug & radiotherapy combos
🌟 Identifies a signature for patient stratification